Lataa...
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
The possible treatments options for metastatic hormone-sensitive prostate cancer (mHSPC) have dramatically increased during the last years. The old backbone, which androgen-deprivation therapy (ADT) is the exclusive approach for hormone-naïve patients, has been disrupted. Despite the fact that sever...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6770296/ https://ncbi.nlm.nih.gov/pubmed/31547436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091355 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|